Column Group II, Lp - Significant Ownership

Signature - Title
/s/ James Evangelista, Attorney-in-Fact - James Evangelista, Attorney-in-Fact
Location
San Francisco, CA
Summary
This page shows a list of all the recent SCHEDULE 13D/G filings made by Column Group II, Lp.

Significant Ownership of Column Group II, Lp

Sym Company Class Ownership Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
RAPT RAPT Therapeutics, Inc. Common Stock, $0.0001 par value 4.9% $1.36M 1.6M Peter Svennilson Dec 23, 2024
ORIC ORIC Pharmaceuticals, Inc. Common Stock, $0.0001 par value per share 3.7% $48.6M 3.64M Peter Svennilson Sep 30, 2025

Schedules 13D/G Reported by Column Group II, Lp:

Sym Target Class Ownership Change Current Shares Change Value Reporting name Form Report Period Date Filed
* An asterisk sign (*) next to the price indicates that the price is likely invalid.